MA42806A - Utilisation d'un extrait d'agrume organique à haute capacité antimicrobienne et de xylitol en tant que système de conservation dans des liquides, des émulsions, des suspensions, des crèmes et des antiacides - Google Patents

Utilisation d'un extrait d'agrume organique à haute capacité antimicrobienne et de xylitol en tant que système de conservation dans des liquides, des émulsions, des suspensions, des crèmes et des antiacides

Info

Publication number
MA42806A
MA42806A MA042806A MA42806A MA42806A MA 42806 A MA42806 A MA 42806A MA 042806 A MA042806 A MA 042806A MA 42806 A MA42806 A MA 42806A MA 42806 A MA42806 A MA 42806A
Authority
MA
Morocco
Prior art keywords
antiacids
xylitol
creams
emulsions
suspensions
Prior art date
Application number
MA042806A
Other languages
English (en)
Inventor
Javier Barraza
Renata Muniz
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MA42806A publication Critical patent/MA42806A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA042806A 2015-05-29 2016-05-26 Utilisation d'un extrait d'agrume organique à haute capacité antimicrobienne et de xylitol en tant que système de conservation dans des liquides, des émulsions, des suspensions, des crèmes et des antiacides MA42806A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562168002P 2015-05-29 2015-05-29

Publications (1)

Publication Number Publication Date
MA42806A true MA42806A (fr) 2018-07-25

Family

ID=56116576

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042806A MA42806A (fr) 2015-05-29 2016-05-26 Utilisation d'un extrait d'agrume organique à haute capacité antimicrobienne et de xylitol en tant que système de conservation dans des liquides, des émulsions, des suspensions, des crèmes et des antiacides

Country Status (8)

Country Link
US (1) US10342841B2 (fr)
EP (1) EP3302420A1 (fr)
CN (1) CN107666910A (fr)
BR (1) BR112017025467A2 (fr)
CA (1) CA2987034C (fr)
MA (1) MA42806A (fr)
RU (1) RU2715906C2 (fr)
WO (1) WO2016196209A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2785424A1 (es) * 2019-04-04 2020-10-06 Alcaraz Pedro Escudero Sales alcalinizantes y procedimientos de obtención
KR102687426B1 (ko) * 2021-02-09 2024-07-23 (주)넥스팜코리아 만다린 추출물을 이용한 항균용 조성물

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2595249B1 (fr) 1986-03-10 1989-12-01 Univ Victor Segalen Bordeaux 2 Composition pharmaceutique consistant en une suspension de carbonate de calcium
CA2085873A1 (fr) 1990-06-22 1991-12-23 Adrian Francis Davis Traitement
US5229137A (en) 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
US5496567A (en) 1993-08-26 1996-03-05 Mclean; Linsey Composition having buffering and nutritional properties
NZ275690A (en) 1993-10-13 1998-08-26 Warner Lambert Co Antacid composition comprising calcium carbonate and a second buffer compound which is calcium citrate and/or calcium phosphate
US5455050A (en) 1993-11-12 1995-10-03 Mcneil-Ppc, Inc. Aqueous antacids with calcium carbonate and magnesium salt
US5498426A (en) * 1994-10-03 1996-03-12 The Procter & Gamble Company Liquid antacid compositions
DE19529862A1 (de) 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
DE69638106D1 (de) 1996-09-30 2010-02-11 Dennis Jones Regulation von Körpergewicht durch Materialien basierend auf Zitrusvariationen
US5976578A (en) 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
US5874112A (en) 1997-03-31 1999-02-23 Mcneil Ppc-Inc. Translucent antacid suspension
US5914135A (en) 1997-04-16 1999-06-22 Mcneil-Ppc, Inc. Liquid antacid compositions
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
AU2446801A (en) 1999-12-23 2001-07-03 Ancile Pharmaceuticals, Inc. Treatment for inflammatory bowel disease (ibd) and related conditions
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
CA2540786A1 (fr) 2005-03-23 2006-09-23 Bioenvelop Agro Inc. Gel de protection buccale
TW200843802A (en) * 2007-02-09 2008-11-16 Drugtech Corp Compositions for improving gastrointestinal nutrient and drug absorption
US20120100231A1 (en) 2009-06-23 2012-04-26 Perla Marc D Antimicrobial Compositions And Methods Of Making And Using The Same
US20100323043A1 (en) 2009-06-23 2010-12-23 Perla Marc D Antimicrobial Compositions and Methods of Making and Using the Same
EP2460409A1 (fr) 2010-12-03 2012-06-06 Nestec S.A. Support pour relargage d'huiles essentielles antimicrobiennes
WO2013103556A1 (fr) 2012-01-05 2013-07-11 The Trustees Of Columbia University In The City Of New York Composition antimicrobienne
ITRM20120499A1 (it) 2012-10-17 2014-04-18 Elio Fabio Bortoli Metodo per la preparazione di conservanti nel settore alimentare
US20170079281A1 (en) * 2015-09-21 2017-03-23 Biosecur Lab Inc. Citrus-based antimicrobial composition

Also Published As

Publication number Publication date
WO2016196209A1 (fr) 2016-12-08
RU2017145941A3 (fr) 2019-10-14
RU2017145941A (ru) 2019-07-02
CA2987034A1 (fr) 2016-12-08
CA2987034C (fr) 2023-03-07
US10342841B2 (en) 2019-07-09
BR112017025467A2 (pt) 2018-08-07
EP3302420A1 (fr) 2018-04-11
CN107666910A (zh) 2018-02-06
RU2715906C2 (ru) 2020-03-04
US20160346341A1 (en) 2016-12-01

Similar Documents

Publication Publication Date Title
EP3411484A4 (fr) Injection de virus adéno-associé simple brin ou auto-complémentaire 9 dans le liquide cérébrospinal
EP3360032A4 (fr) Intégration d'un contenu dans des applications non de navigateur
DK3355701T3 (da) Væskeformig ernæringssammensætning, der omfatter micellært kasein og hydrolyseret valleprotein
MX2017002239A (es) Composicion que contiene cineol para la administracion nasal.
EP3718914A4 (fr) Récipient distributeur de contenu liquide
ES2864951T8 (es) Emulsión que contiene esterquats líquidos y espesantes poliméricos
CL2014002123A1 (es) Una columna de extraccion de liquido-liquido a contracorriente adaptada para el flujo de dos o mas liquidos en su interior, comprende una primera y una segunda entrada para una primera y una segunda corriente de alimentacion de liquido, una primera y una segunda salida para una corriente de producto y de subproducto respectivamente, y una seccion estatica; y procedimiento asociado.
EP3393231A4 (fr) Contenant d'expédition de fruits et légumes
EP3442873A4 (fr) Système applicateur d'imprimante d'étiquettes
EP3377152A4 (fr) Système intégré d'administration de liquide
CL2015000218A1 (es) Agente liquido topico para las uñas y/o la piel para prevencion o tratamiento de dermatofitosis que comprende un formador de pelicula que contiene un polimero, un compuesto derivado de 2-(1h-pirazol-1-il)fenol, un alcohol inferior y un agente que incrementa la viscosidad.
ITUB20151929A1 (it) Contenitore di prodotto cosmetico fluido con polimero superassorbente.
MA42806A (fr) Utilisation d'un extrait d'agrume organique à haute capacité antimicrobienne et de xylitol en tant que système de conservation dans des liquides, des émulsions, des suspensions, des crèmes et des antiacides
EP3375511A4 (fr) Système d'approvisionnement en liquide
EP3383649A4 (fr) Produit d'essuyage absorbant l'huile
EP3353277A4 (fr) Récipient d'échantillon dirigeant le liquide
MA46597A (fr) Utilisation d'extrait d'agrumes biologiques à capacité antimicrobienne élevée en tant que système de conservation dans des liquides, des émulsions, des suspensions, des crèmes et des anti-acides
BR112018004267A2 (pt) concentrado líquido para conservar cosméticos
BR112015002596A2 (pt) distribuidor para líquidos cosméticos ou farmacêuticos.
MA47177A (fr) Système d'emballage biocide
IT201600087999U1 (it) Pallet espositore di plastica.
HUE045182T2 (hu) Lemezszerû alsó állvány, különösen folyadékszállító és folyadéktároló tartályokhoz
FR2996128B1 (fr) Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.
CL2014003249A1 (es) Un sistema biodegradable antifúngico para contener y transportar alimentos, en especial frutas frescas, además de la composición de dicho sistema.
EP3434610A4 (fr) Système d'application d'étiquette